| Dr Zuhair Habib Yaseen, MD | |
|
100 Navarre Pl Ste 4400, South Bend, IN 46601-1100 | |
| (574) 544-5580 | |
| (574) 544-5579 |
| Full Name | Dr Zuhair Habib Yaseen |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 35 Years |
| Location | 100 Navarre Pl Ste 4400, South Bend, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093705675 | NPI | - | NPPES |
| 200527950 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 01060726A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hospital Of South Bend | South bend, IN | Hospital |
| Community Hospital Of Bremen Inc | Bremen, IN | Hospital |
| Saint Joseph Regional Medical Center | Mishawaka, IN | Hospital |
| Elkhart General Hospital | Elkhart, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Beacon Medical Group Inc | 1254243306 | 452 |
News Archive
People today constantly encounter claims such as "Advil kills pain," "coffee prevents depression," or "Hilary promises amnesty" as brands, news outlets and social media sites vie for our attention-yet few people take the time to investigate whether these statements are true.
Boston Scientific Corporation announces that it has completed enrollment in the REPRISE I clinical trial, which is designed to evaluate the acute safety of the Lotus Aortic Valve System, the first transcatheter aortic valve replacement (TAVR) device of its kind for patients with severe aortic valve stenosis that is both fully repositionable and retrievable prior to release.
Some European countries could make better provision for disabled children to allow them to participate in life on an equal basis with others, concludes a large study published on bmj.com.
Forest Laboratories, Inc. and Almirall, S.A. today announced positive topline results from AUGMENT COPD, the second six-month pivotal phase III clinical trial evaluating the efficacy and safety of investigational fixed dose combinations of aclidinium bromide and formoterol fumarate, delivered in the Pressair (Genuair outside the USA) inhaler.
Amgen today announced primary results of a pivotal Phase 3 trial demonstrating that XGEVA significantly increased bone metastasis-free survival for more than four months in men with castrate-resistant metastatic prostate cancer that has not yet spread to bone.
› Verified 9 days ago
| Entity Name | Beacon Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033161617 PECOS PAC ID: 1254243306 Enrollment ID: O20031105000657 |
News Archive
People today constantly encounter claims such as "Advil kills pain," "coffee prevents depression," or "Hilary promises amnesty" as brands, news outlets and social media sites vie for our attention-yet few people take the time to investigate whether these statements are true.
Boston Scientific Corporation announces that it has completed enrollment in the REPRISE I clinical trial, which is designed to evaluate the acute safety of the Lotus Aortic Valve System, the first transcatheter aortic valve replacement (TAVR) device of its kind for patients with severe aortic valve stenosis that is both fully repositionable and retrievable prior to release.
Some European countries could make better provision for disabled children to allow them to participate in life on an equal basis with others, concludes a large study published on bmj.com.
Forest Laboratories, Inc. and Almirall, S.A. today announced positive topline results from AUGMENT COPD, the second six-month pivotal phase III clinical trial evaluating the efficacy and safety of investigational fixed dose combinations of aclidinium bromide and formoterol fumarate, delivered in the Pressair (Genuair outside the USA) inhaler.
Amgen today announced primary results of a pivotal Phase 3 trial demonstrating that XGEVA significantly increased bone metastasis-free survival for more than four months in men with castrate-resistant metastatic prostate cancer that has not yet spread to bone.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Zuhair Habib Yaseen, MD 3245 Health Dr Ste 100, Granger, IN 46530-1380 Ph: (574) 647-2129 | Dr Zuhair Habib Yaseen, MD 100 Navarre Pl Ste 4400, South Bend, IN 46601-1100 Ph: (574) 544-5580 |
News Archive
People today constantly encounter claims such as "Advil kills pain," "coffee prevents depression," or "Hilary promises amnesty" as brands, news outlets and social media sites vie for our attention-yet few people take the time to investigate whether these statements are true.
Boston Scientific Corporation announces that it has completed enrollment in the REPRISE I clinical trial, which is designed to evaluate the acute safety of the Lotus Aortic Valve System, the first transcatheter aortic valve replacement (TAVR) device of its kind for patients with severe aortic valve stenosis that is both fully repositionable and retrievable prior to release.
Some European countries could make better provision for disabled children to allow them to participate in life on an equal basis with others, concludes a large study published on bmj.com.
Forest Laboratories, Inc. and Almirall, S.A. today announced positive topline results from AUGMENT COPD, the second six-month pivotal phase III clinical trial evaluating the efficacy and safety of investigational fixed dose combinations of aclidinium bromide and formoterol fumarate, delivered in the Pressair (Genuair outside the USA) inhaler.
Amgen today announced primary results of a pivotal Phase 3 trial demonstrating that XGEVA significantly increased bone metastasis-free survival for more than four months in men with castrate-resistant metastatic prostate cancer that has not yet spread to bone.
› Verified 9 days ago
Mayank Kumar Mittal, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 610 N Michigan St Ste 400, South Bend, IN 46601 Phone: 574-647-8120 Fax: 574-647-8111 | |
Dr. Steven P. Crowell, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 211 N Eddy St, South Bend, IN 46617 Phone: 574-237-9340 Fax: 574-239-1474 | |
Muhammad Shakil Aslam, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 610 N Michigan St Ste 400, South Bend, IN 46601 Phone: 574-647-8120 Fax: 574-647-8111 | |
Monika Niemiec, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 615 N Michigan St, 1st Fl Hospitalist Ste, South Bend, IN 46601 Phone: 574-647-3050 Fax: 574-647-1094 | |
Dr. Travis Weaver, D.O. Gastroenterology Medicare: Medicare Enrolled Practice Location: 1815 E Ireland Rd, South Bend, IN 46614 Phone: 574-647-1700 Fax: 574-647-7572 | |
Dr. Thomas P Barbour, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 211 N Eddy St, South Bend, IN 46617 Phone: 574-237-9340 Fax: 574-239-1474 | |
Dr. Ahmed A Abdel-latief, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 211 N Eddy St, South Bend, IN 46617 Phone: 574-239-1433 Fax: 574-239-1438 |